Efficacy of Extracorporeal Shockwave Therapy on Ultrasonography Changes of Upper Trapezius Myofas… (NCT06267755) | Clinical Trial Compass
UnknownNot Applicable
Efficacy of Extracorporeal Shockwave Therapy on Ultrasonography Changes of Upper Trapezius Myofascial Trigger Points in Patients With Non Specific Neck Pain
60 participantsStarted 2024-02-20
Plain-language summary
this study will be conducted to investigate the effect of Extracorporeal Shockwave Therapy on Ultrasonography Changes of Upper Trapezius Myofascial Trigger Points in Patients With Non Specific Neck Pain
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Sixty patients receiving a diagnosis of non-specific neck pain with upper trapezius myofascial trigger points by an orthopaedist physician.
* Body mass index of participants was normal less than (30 kg/m2)(Al-asadi, 2018).
* Age over 18 years.
* Presence of taught band.
* Presence of hyper irritable spot in a taught band, and reproduction of the typical referred pain pattern of the myofascial trigger point in response to compression
Exclusion Criteria:
* Having signs and symptoms of neurological disorders that cause nerve root compression.
* Headache as a consequence of specific headache diagnosis.
* Having a history of specific signs of malignancy, or infection.
* Having a history of trauma with or without proven structural disorders in the region of the neck, shoulder, and head (e.g. whiplash).
* Having signs and symptoms of cerebrovascular insufficiency.
* Having a severe chronic disease of the locomotor system (e.g. polyarthritis, muscular disease
* Any participant with contraindications to shock wave therapy